Stereochemistry | ABSOLUTE |
Molecular Formula | C24H46O6 |
Molecular Weight | 430.6184 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(OC[C@H](O)[C@H]1O)[C@H](O)COC(=O)CCCCCCCCCCCCCCCCC
InChI
InChIKey=HVUMOYIDDBPOLL-XWVZOOPGSA-N
InChI=1S/C24H46O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22(27)29-19-21(26)24-23(28)20(25)18-30-24/h20-21,23-26,28H,2-19H2,1H3/t20-,21+,23+,24+/m0/s1
Molecular Formula | C24H46O6 |
Molecular Weight | 430.6184 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Sorbitan monostearate (Span 60) is a non-ionic surfactant with emulsifying, dispersing, and wetting properties used as a food additive, additive in mixtures for drug use and in skin care products. It is approved for use by FDA in quantities not exceeding the amount reasonably required to accomplish the intended effect. 0.5-5% of Liposorb® S (sorbitan monostearate) is used for oil-in-water emulsions in combination with a high hydrophilic-lipophilic balance emulsifier to produce smooth lotions and creams in skin and hair care, make-up bases, and mild cleaning products. Sorbitan monostearate based organogels and vesicles (niosomes) formulated to enhance the oral bioavailability were characterized for use as a drug delivery vehicle. In combination with other non-ionic surfactants sorbitan monostearate is patented for use in vaccine formulations as a saponin-containing adjuvant for oil-in-water injectable emulsions. It is fatty acid ester of sorbitan (a sorbitol derivative) and stearic acid sometimes called synthetic wax. Has low hydrophilic-lipophilic balance. Non-toxic.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|